Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this
Vaxcyte, Inc. vs Halozyme Therapeutics, Inc.: key figures
| Rank | #1939 | #1850 |
|---|---|---|
| Price | $67.53 | $100.67 |
| Market cap | $10.63B | $11.46B |
| Shares Outstanding | 157.39M | 113.80M |
| Change (1 day) | +5.70% | -0.99% |
| Change (1 year) | +48.25% | +41.41% |
The other way round: HALO with the market cap of PCVX
If Halozyme Therapeutics, Inc. (HALO) had the market cap of Vaxcyte, Inc. (PCVX), one HALO would cost $93.40, 7.22% less than today's price of $100.67.
Price of HALO with the Market Cap of PCVXPrice of PCVX with the Market Cap of HALO: the last 12 months
The price of one PCVX if Vaxcyte, Inc. had the market cap of Halozyme Therapeutics, Inc., at the end of each month. Highest: $94.40 (Oct 2026). Lowest: $55.04 (Apr 2026).
- $57.92 Dec 2025
- $61.72 Jan 2026
- $60.12 Feb 2026
- $55.88 Mar 2026
- $55.04 Apr 2026
- $56.35 May 2026
- $66.28 Jun 2026
- $68.10 Jul 2026
- $87.47 Aug 2026
- $90.69 Sep 2026
- $94.40 Oct 2026
- $74.22 Nov 2026
Questions about Vaxcyte, Inc. and Halozyme Therapeutics, Inc.
What would the price of Vaxcyte, Inc. be with the market cap of Halozyme Therapeutics, Inc.?
If Vaxcyte, Inc. (PCVX) had the market cap of Halozyme Therapeutics, Inc. (HALO), one PCVX would cost $72.79, 1.08 times today's price of $67.53.
How much bigger is Halozyme Therapeutics, Inc. than Vaxcyte, Inc.?
The market cap of Halozyme Therapeutics, Inc. ($11.46B) is 1.08 times that of Vaxcyte, Inc. ($10.63B). In Dec 2025 the gap was 1.26 times.
What would the price of Halozyme Therapeutics, Inc. be with the market cap of Vaxcyte, Inc.?
If Halozyme Therapeutics, Inc. (HALO) had the market cap of Vaxcyte, Inc. (PCVX), one HALO would cost $93.40, 7.22% less than today's price of $100.67.
How is this price calculated?
The market cap of Halozyme Therapeutics, Inc. ($11.46B) is divided by the number of PCVX in circulation (157.39M). Market cap is the price multiplied by the number of coins or shares in circulation.